Lymphatic Malformations Associated With Pik3ca Mutation clinical trials

Explore recruiting lymphatic malformations associated with pik3ca mutation clinical trials.

Recruiting lymphatic malformations associated with pik3ca mutation studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphatic Malformations Associated With Pik3ca Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A two-stage double-blind, randomized, placebo-controlled study to assess the efficacy, safety and pharmacokinetics of alpelisib in pediatric and adult patients with lymphatic malformations associated with a PIK3CA mutation

France, Italy, Germany, Spain, Belgium, Netherlands +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Lymphatic Malformations Associated With Pik3ca Mutation trials by city

Lymphatic Malformations Associated With Pik3ca Mutation in Toronto Lymphatic Malformations Associated With Pik3ca Mutation in Vancouver Lymphatic Malformations Associated With Pik3ca Mutation in Montreal Lymphatic Malformations Associated With Pik3ca Mutation in Calgary Lymphatic Malformations Associated With Pik3ca Mutation in Edmonton Lymphatic Malformations Associated With Pik3ca Mutation in Ottawa Lymphatic Malformations Associated With Pik3ca Mutation in Winnipeg Lymphatic Malformations Associated With Pik3ca Mutation in Quebec City Lymphatic Malformations Associated With Pik3ca Mutation in Hamilton Lymphatic Malformations Associated With Pik3ca Mutation in Kitchener Lymphatic Malformations Associated With Pik3ca Mutation in London Lymphatic Malformations Associated With Pik3ca Mutation in Halifax Lymphatic Malformations Associated With Pik3ca Mutation in New York Lymphatic Malformations Associated With Pik3ca Mutation in Los Angeles Lymphatic Malformations Associated With Pik3ca Mutation in Chicago Lymphatic Malformations Associated With Pik3ca Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease